Evidence map›Paper›PMID 38155227›Full record

ArticleScientific reports2023

Reduced HIV/AIDS diagnosis rates and increased AIDS mortality due to late diagnosis in Brazil during the COVID-19 pandemic.

Lucas Almeida Andrade, Thiago de França Amorim, Wandklebson Silva da Paz, Mariana do Rosário Souza, Emerson Lucas S Camargo, Débora Dos Santos Tavares, Shirley Verônica M A Lima, Enaldo Vieira de Melo, Marco Aurélio de O Góes, Rodrigo Feliciano do Carmo and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Lucas Almeida Andrade *Health Science Graduate Program, Universidade Federal de Sergipe, Aracaju, SE, Brazil. lucas_almeidandrade@hotmail.com.
Thiago de França Amorim *Graduate Program in Teaching and Teacher Training, Universidade Federal de Alagoas, Arapiraca, AL, Brazil.
Wandklebson Silva da PazTropical Medicine Graduate Program, Universidade Federal de Pernambuco, Recife, PE, Brazil.
Mariana do Rosário SouzaHealth Science Graduate Program, Universidade Federal de Sergipe, Aracaju, SE, Brazil.
Emerson Lucas S CamargoRibeirão Preto College of Nursing, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Débora Dos Santos TavaresDepartment of Health Science, Universidade Federal de Sergipe, Lagarto, SE, Brazil.
Shirley Verônica M A LimaDepartment of Nursing, Universidade Federal de Sergipe, Lagarto, SE, Brazil.
Enaldo Vieira de MeloDepartment of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil.
Marco Aurélio de O GóesDepartment of Medicine, Universidade Federal de Sergipe, Aracaju, Brazil.
Rodrigo Feliciano do CarmoCollege of Pharmaceutical Sciences, Federal University of Vale do São Francisco, Petrolina, PE, Brazil.
Carlos Dornels F de SouzaCollege of Medicine, Federal University of Vale do São Francisco, Petrolina, PE, Brazil.
Allan Dantas Dos SantosDepartment of Nursing, Universidade Federal de Sergipe, Lagarto, SE, Brazil.
Álvaro Francisco L de SousaInstitute of Teaching and Research, Hospital Sírio-Libânes, São Paulo, SP, Brazil.
Isabel Amélia C MendesRibeirão Preto College of Nursing, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Abelardo Silva-JúniorHealth Science Graduate Program, Universidade Federal de Alagoas, Maceió, AL, Brazil.
Wagnner José N PortoHealth Science Graduate Program, Universidade Federal de Alagoas, Maceió, AL, Brazil.
Márcio Bezerra-SantosHealth Science Graduate Program, Universidade Federal de Sergipe, Aracaju, SE, Brazil.
Universidade Federal de Sergipe · BRUniversidade Federal de Alagoas · BRUniversidade de Ribeirão Preto · BRUniversidade Federal do Vale do São Francisco · BRHospital Sírio-Libanês · BRUniversidade Federal de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has severely affected global health, leading to the suspension of numerous routine healthcare services and posing challenges in efforts to control other diseases, such as HIV/AIDS. This study aimed to assess the impact of the COVID-19 pandemic on HIV/AIDS diagnoses and mortality rates in Brazil during 2020 and 2021. The percentage change was calculated to determine whether there was an increase or decrease in HIV/AIDS diagnoses and mortality, considering the average numbers from the last 5 years. Additionally, a Joinpoint regression model and an interrupted time series analysis were applied to assess time trends before and after the onset of the pandemic. Lastly, choropleth maps were prepared. We observed a reduction of 22.4% (2020) and 9.8% (2021) in the diagnosis of HIV/AIDS in Brazil. Conversely, there was a significant increase in the percentage change of late diagnosis of AIDS deaths in 2020 (6.9%) and 2021 (13.9%), with some states showing an increase of over 87%. Decreasing time trends in the diagnosis of HIV/AIDS were identified before the pandemic in Brazil, especially in the Southeast and South regions, and then time trends stabilized after including the pandemic years. Along with the dissemination of COVID-19, there was a reduction in the diagnosis of HIV/AIDS and an increase in late diagnosis AIDS deaths, signaling a serious impact of the pandemic on HIV/AIDS control strategies in Brazil. Therefore, we highlight the need for continuous efforts to control both diseases, that is, maintaining regular health services even in crisis situations.

Indexed as

Acquired Immunodeficiency SyndromeCOVID-19HIV InfectionsBrazilCOVID-19 TestingDelayed DiagnosisHumansPandemics

Identifiers

PMID38155227
PMCPMC10754892
OpenAlexW4390346452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.